FTSE 100 scales 5-month high with 14% gain in trading 8 days as markets recover from Covid-19 crash

3 min read | November 12, 2020 02:35 PM GMT | By Hina Chowdhary

Summary

  • The FTSE 100 has amassed a gain of 14.43 per cent to 6,382.10 (11 November) in last eight trading sessions
  • In the corresponding duration, the Great Britain pound has also strengthened against the US dollar in the foreign exchange market

The UK stock markets have been largely rising from the last eight trading sessions recovering considerable losses realised due to the Covid-19 fears led crash in February-March. 

The benchmark FTSE 100 has advanced more than 14 per cent in the last eight days tracking the upbeat Wall Street and a market-wide buying on the back of substantial news of progress in the coronavirus vaccine development. 

With the recent spurt in the FTSE 100, the index is now trading at a nearly five-month high level following the surge in shares of varied sectors.

FTSE 100 at 5-month high

The FTSE 100 has amassed a gain of 14.43 per cent to 6,382.10 (11 November) in exactly eight trading sessions from a level of 5,577.27 as on 30 October. The productive news around the Covid-19 SARS-CoV vaccine has reinstated confidence amid all the investor classes. The markets in Great Britain as well as in other major economies across the European Union have defied the fears of after-effects arising due to recent lockdowns. 

FTSE 100 (1-month performance)

(Source: Thomson Reuters)

GBP strengthens vs USD

In the corresponding duration, the Great Britain Pound has strengthened against the US dollar in the foreign exchange market. 

According to the latest data available with the Bank of England, the British Pound Sterling has gained 2.04 per cent in the last eight sessions. 

As of 11 November, a unit of Great Britain pound translates into 1.3197 United States dollar as compared to an exchange rate of 1.2933 USD in one pound. The persisting strength of the currency has also contributed to the upsurge in the equity markets. 

US presidential elections

The outcome of US presidential elections has also assisted the markets in the upward trajectory with the Democratic Party candidate Joe Biden claiming a victory in US presidential election 2020. 

He won with a considerable margin as compared to the final seat share of Republican Party candidate and incumbent US President Donald Trump. 

Interestingly, stock markets across the world rallied continuously even when the counting of votes of US presidential elections was underway. 

Pfizer-BioNTech Covid-19 vaccine update

The FTSE 100 index approximately scooped 6 per cent due to the optimism about the outcome of US presidential elections.  The markets furthered the gain with a single-day spike of more than 4 per cent after the pharmaceutical majors Pfizer Inc. and BioNTech SE jointly announced the development in the ongoing Phase 3 trials of coronavirus vaccine. The vaccine candidate has been found to be more than 90 per cent effective in preventing deadly SARS-CoV-2 infection. 

Goldman Sachs view on FTSE 100

After the breakthrough in development of coronavirus vaccine, the Goldman Sachs, the global investment banking firm predicted a level of 7,200 for the FTSE 100 by the end of 2021. The psychological level of 7,200 is nearly 13 per cent higher as compared to the previous closing of 6,382.10. 

However, the headline FTSE 100 index had touched a high of 7,674.56 on closing basis in the present year itself. Starting the current year on a positive footing, the FTSE 100 gained 1.75 per cent in about 12 trading days to hit a yearly closing high of 7,674.56 on 17 January.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next